TY - JOUR
T1 - Acute pharmacological modulation of mGluR8 reduces measures of anxiety
AU - Duvoisin, Robert M.
AU - Pfankuch, Tim
AU - Wilson, Julie M.
AU - Grabell, Julie
AU - Chhajlani, Vijay
AU - Brown, Dean G.
AU - Johnson, Edwin
AU - Raber, Jacob
N1 - Funding Information:
We thank Jessica Siegel for help with the behavioral testing, Heather Gosnell and Danny Winder for discussions and advice in writing the manuscript. This work was supported by NIMH R01 MH77647.
PY - 2010/10
Y1 - 2010/10
N2 - Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.
AB - Metabotropic glutamate receptors (mGluRs), which are coupled to second messenger pathways via G proteins, modulate glutamatergic and GABAergic neurotransmission. Because of their role in modulating neurotransmission, mGluRs are attractive therapeutic targets for anxiety disorders. Previously we showed that mGluR8-/- male mice showed higher measures of anxiety in the open field and elevated plus maze than age-matched wild-type mice. In this study, we assessed the potential effects of acute pharmacological modulation of mGluR8 on measures of avoidable and unavoidable anxiety. In addition to wild-type mice, we also tested apolipoprotein E-deficient (Apoe-/-) mice, as these mice show increased levels of anxiety-like behaviors and therefore might show an altered sensitivity to mGluR8 stimulation. mGluR8 stimulation with the specific agonist DCPG, or modulation with AZ12216052, a new, positive allosteric modulator of mGluR8 reduced measures of anxiety in both wild-type mice. The effects of mGluR8 positive allosteric modulators, which only affect neurotransmission in the presence of extracellular glutamate, seem particularly promising for patients with anxiety disorders showing benzodiazepine insensitivity.
KW - Allosteric modulator
KW - Behavior
KW - Group-III mGluR
KW - Metabotropic
UR - http://www.scopus.com/inward/record.url?scp=77953020355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953020355&partnerID=8YFLogxK
U2 - 10.1016/j.bbr.2010.04.006
DO - 10.1016/j.bbr.2010.04.006
M3 - Article
C2 - 20385173
AN - SCOPUS:77953020355
SN - 0166-4328
VL - 212
SP - 168
EP - 173
JO - Behavioural Brain Research
JF - Behavioural Brain Research
IS - 2
ER -